Liječnički vjesnik, Vol. 135 No. 11-12, 2013.
Professional paper
CLINICAL GUIDELINES FOR DIAGNOSING, TREATMENT AND MONITORING PATIENTS WITH PROSTATE CANCER – CROATIAN ONCOLOGY SOCIETY AND CROATIAN UROLOGY SOCIETY, CROATIAN MEDICAL ASSOCIATION
Mladen Solarić
Mislav Grgić
Tomislav Omrčen
Marija Petković
Ana Fröbe
Nenad Belaj
Robert Zorica
Božo Krušlin
Gordana Đorđević
Željko Kaštelan
Boris Ružić
Ivan Gilja
Ivan Krolo
Katarina Vilović
Davor Librenjak
Eduard Vrdoljak
Marijan Šitum
Ranka Štern Padovan
Željko Vojnović
Abstract
Prostate adenocarcinoma is the second most common solid neoplasm in male population in Croatia. It rarely causes symptoms unless it is advanced. The finding of PSA rise is the most common reason for diagnostic workout. Treatment plan is based on TNM classification, Gleason score and PSA. Clinically localized disease is successfully treated by radical prostatectomy or radiotherapy with or without hormonal therapy. Locally advanced disease is treated with radiotherapy and hormonal therapy. Metastatic disease can be controlled for many years by androgen deprivation. For castration resistant disease appropriate treatment is chemotherapy or secondary hormonal therapy. The following paper presents the clinical guidelines in order to standardize procedures and criteria for the diagnosis, management, management, treatment and monitoring of patients with prostate cancer in the Republic of Croatia.
Keywords
Prostatic neoplasms – diagnosis, pathology, therapy; Practice guidelines as topic; Croatia
Hrčak ID:
172515
URI
Publication date:
30.12.2013.
Visits: 1.530 *